University of West London Featured PhD Programmes
Loughborough University Featured PhD Programmes
University of Reading Featured PhD Programmes

Pharmacy / Pharmaceutics (death) PhD Projects, Programs & Scholarships

We have 14 Pharmacy / Pharmaceutics (death) PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 14 Pharmacy / Pharmaceutics (death) PhD Projects, Programs & Scholarships

Property based design of mitochondria targeted molecules

Applications are invited from Graduates in Chemistry, Pharmacy and Medicinal Chemistry Master’s level programs to join our group within the Faculty of Medical Sciences looking at novel approaches to the design of the next generation of mitochondria targeted therapeutic agents. Read more

Development of a personalized therapy for pulmonary arterial hypertension (PAH)

  Research Group: Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Using ex-vivo genetic systems as models to detect genetic susceptibility to co-morbidities in Covid 19 infection, and to test specific anti-inflammatory / antiviral drugs in Covid 19 infection

  Research Group: Chemistry and Biosciences
Research has shown that certain individuals are more susceptible to SARS-CoV-2. Approximately, 20–51% of COVID-19 patients presented with a least one co-morbidity on admission, with diabetes (10–20%) hypertension (10–15%) and other cardiovascular and cerebrovascular diseases (7–40%) being most prevalent. Read more

Re-purposing established drugs for the resolution of pulmonary arterial hypertension (PAH)

  Research Group: Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products

  Research Group: Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more

Anaemia of Chronic Kidney Disease: An All-Wales primary and secondary care prevalence and incidence study

Aim. The project will investigate the prevalence of ACKD in Wales across primary and secondary care. It will follow patients with CKD G3-5 to explore the association between ACKD and hospitalisation and mortality. Read more

Mitigation of human drug-induced proarrythmia and cardiotoxicity of oncology therapeutics

Cardiotoxicity is a major complication of many anticancer therapies, impacting the quality of life and overall survival of the patient, manifesting as both an acute toxicity (days/weeks) and frequently a chronic toxicity occurring months/years after conclusion of therapy. Read more
  • 1

Filtering Results